Purchases and Sales Made in Q1 2022 in Design Therapeutics, Inc. (DSGN)
This table provides information about the institutional ownership of Design Therapeutics, Inc. (DSGN) during Q1 2022. The information is specifically focused on institutions that hold shares of Design Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Apr 29, 2022
Q1 2022
|
Sg Americas Securities, LLC
|
SELL
|
- |
-5.64KClosed |
$63K - $118K
|
0
$0
|
|
|
Mar 30, 2023
Q1 2022
|
Metropolitan Life Insurance CO
New York, NY |
SELL
|
- |
-6.02K- 74.81% |
$67.3K - $126K
|
2.03K
$9.16K
|
|
|
May 12, 2022
Q1 2022
|
Metropolitan Life Insurance CO
New York, NY |
SELL
|
- |
-6.02K- 74.81% |
$67.3K - $126K
|
2.03K
$9.16K
|
|
|
May 16, 2022
Q1 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-9.29K- 93.43% |
$104K - $194K
|
653
$2.95K
|
|
|
May 12, 2022
Q1 2022
|
Citigroup Inc
|
SELL
|
- |
-9.48K- 33.61% |
$106K - $198K
|
18.7K
$84.6K
|
|
|
May 16, 2022
Q1 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-9.62KClosed |
$107K - $201K
|
0
$0
|
|
|
May 10, 2022
Q1 2022
|
Td Asset Management Inc
|
SELL
|
- |
-21.4K- 32.56% |
$239K - $447K
|
44.3K
$200K
|
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-26K- 67.0% |
$291K - $543K
|
12.8K
$57.9K
|
|
|
May 13, 2022
Q1 2022
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-54.4K- 10.25% |
$608K - $1.14M
|
477K
$2.15M
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-200KClosed |
$2.23M - $4.18M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-214K- 27.12% |
$2.39M - $4.46M
|
574K
$2.59M
|
|
|
May 16, 2022
Q1 2022
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
SELL
|
- |
-281KClosed |
$3.14M - $5.87M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-283K- 5.21% |
$3.17M - $5.92M
|
5.16M
$23.3M
|